bit.bio
bit.bio Cambridge UK company
- Headquarters
- Cambridge
- Sector
- healthcare
- Incorporated
- 2016
What does bit.bio do?
bit.bio reprograms human stem cells into specific cell types on demand — consistently and at scale, which conventional methods struggle with. Those cells are used for research, drug discovery and cell therapy.
How does bit.bio work?
Switches on the specific genes that define a cell type, so a stem cell becomes a neuron or a muscle cell deterministically rather than through slow and variable coaxing.
What does bit.bio offer?
Human cells to order, sold to research labs, drug discovery teams and cell therapy developers.
Who runs bit.bio?
bit.bio has 8 currently appointed directors.
- Corneliu Chiriac
- Mark Reinhard, Dr Kotter
- Klevin Lo
- David, Lord Prior
- Emma Elizabeth Ward
- Keying Xi
- Jonathan Simon, Dr Milner
- Gregory Paul, Sir Winter
Currently appointed officers only, from the Companies House register. Directors who have resigned are excluded — naming someone who left as running the company is worse than naming nobody.
Where is bit.bio based?
bit.bio is headquartered in Cambridge, outside London. It was incorporated in 2016. Other AI companies in Cambridge →
Why does bit.bio matter to a UK operator?
Reliable human cells on demand is infrastructure the rest of British biotech builds on. Cambridge, and the kind of company whose customers are other companies you have heard of.
Company record
Registered as BIT BIO LIMITED, company 10466798, a private limited company, incorporated on 7 November 2016. Registered office: 3rd Floor 1 Ashley Road, Altrincham, Cheshire, United Kingdom, WA14 2DT. SIC 72190 - Other research and experimental development on natural sciences and engineering.
Looked up on the register. Of the first 83 numbers supplied to this directory, 12 belonged to entirely different businesses.
What else is Torus tracking near bit.bio?
6 other UK companies working in healthcare:
6 other AI companies headquartered in Cambridge: